NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Multi-Modal Cancer Therapies > Oxford Cancer launched at the University of Oxford

Oxford Cancer launched at the University of Oxford

14 July 2021 · Listed under Multi-Modal Cancer Therapies

Oxford Cancer has been launched to represent and coordinate cancer research in Oxford.

The pan-divisional initiative has been launched at the University of Oxford, bringing together the collective force of cancer research, outreach and care that happen across the city.

With more than 900 cancer-related researchers across five Oxford University Hospitals (OUH) and University divisions, Oxford staff are uniquely placed to solve key cancer research challenges through their innovative research discoveries.

The Oxford Cancer research theme will demonstrate the role Oxford researchers play in delivering cutting-edge research dedicated to tackling one of the biggest causes of death worldwide.

Together, the University and OUH have strengths in a wide variety of areas, including immunology, data science, cell biology, physical science and drug development. Oxford Cancer aims to bring this expertise together to facilitate multi-disciplinary research across its partners.

It ultimately aims to solve the key challenges cancer represents through developing and delivering novel strategies for early detection and curative treatment of a range of different cancer types. This approach will be informed by the latest fundamental scientific discoveries and underpinned by world leading data science and technological developments that are unique to Oxford.

This new network will not only facilitate University of Oxford and OUH staff with their work, it will also break down the barriers to research facilities and the expertise that can help researchers achieve greater impact for their discoveries.

Oxford Cancer has resources available to all Oxford researchers who feel their work is relevant to cancer research. They are encouraged to join the Oxford Cancer community to benefit from these services and received the monthly newsletter with cancer research and Oxford updates.

Professor Mark Middleton, the NIHR Oxford BRC Co-theme Lead for Cancer and co-Director of Oxford Cancer, said: “We are very excited to launch the new Oxford Cancer network, with the aim of bringing together all those with a shared interest in cancer, to address urgent and emerging cancer patient needs, informed by the best basic science.”

← Study investigating targeted drug delivery by focused ultrasound for pancreatic cancer opens
First person receives drug designed to re-sensitise patients to cancer treatment →

News

  • Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination 24 May 2022
  • BRC study outlines researchers training needs and barriers 20 May 2022
  • Three new Blood and Transplant Research Units created in Oxford 18 May 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre